INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

Vor Biopharma Inc.

VORCIK 0001817229

EDGAR filingsOpen in network
Price$18.66
1 year-9.2%
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score9
Connections with evidence5

VOR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
JW
Joustra WouterDirector
VORVor Biopharma Inc.
Grant or award
A—
3,000 sh
Dec 18, 2025Dec 19, 2025

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 5, 2026
  • ← Holds over 5% ofevidence
    FMR LLC10.7% of class · Schedule 13G · Nov 4, 2026
  • ← Insider ofevidence
    Joustra WouterDirector · Dec 19, 2025
  • ← Insider ofevidence
    Levin Andrew DavidDirector · Dec 19, 2025
  • ← Insider ofevidence
traded Dec 18, 2025
+1d
SEC FORM 4

Evidence

9
LD
Levin Andrew DavidDirector
VORVor Biopharma Inc.
Grant or award
A—
3,000 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC FORM 4

Evidence

9
ZC
Zuraw Qing CheChief Development Officer
VORVor Biopharma Inc.
Disposition to issuer
D—
218.7K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

9
ZC
Zuraw Qing CheChief Development Officer
VORVor Biopharma Inc.
Grant or award
A—
218.7K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

Zuraw Qing Che
Chief Development Officer · Dec 9, 2025

Planned sales and 5% stakes

Form 144, 13D and 13G
  • FMFMR LLCPassive holder · crossed on Sep 30, 2026 · 6.32M shares10.7% of class13G amendment · filed Nov 5, 2026